Tin tức & Cập nhật

Chỉ hiển thị Multimedia

PROTEUS sets new course for prostate cancer

11 Jun 2026 bởi

In the final analysis of the phase III PROTEUS trial, perioperative apalutamide + androgen deprivation therapy (APA+ADT) improves the curative success of radical prostatectomy (RP) in men with high-risk localized or locally advanced prostate cancer (HR LPC/LAPC).

PROTEUS sets new course for prostate cancer

11 Jun 2026

Azithromycin of little benefit in preschool-age children with acute wheezing

11 Jun 2026

Azithromycin appears to only be as good as placebo in the treatment of preschool-age children presenting to the emergency department (ED) with moderate-to-severe acute wheezing, according to a study.

Azithromycin of little benefit in preschool-age children with acute wheezing

11 Jun 2026

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

10 Jun 2026

Dupilumab has been shown to reduce symptomatic, endoscopic, and histological eosinophilic esophagitis (EoE) markers for patients treated in routine practice, as shown in the retrospective DUPEOETALY study.

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

10 Jun 2026

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

10 Jun 2026 bởi

The novel antisense oligonucleotide bepirovirsen has induced functional cure in one-fifth of patients with chronic hepatitis B virus (HBV) infection in the phase 3 B-Well 1 and B-Well 2 trials.

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

10 Jun 2026

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

A significant proportion of rheumatology patients have been diagnosed with anxiety, depression, or fibromyalgia (FM), reveals a study, noting the importance of including screening for clinical decisions at all routine encounters.

Rheumatology patients must undergo screening for anxiety, depression, FM: study

10 Jun 2026

Heavy alcohol consumption raises CRC risk

10 Jun 2026 bởi

Individuals with high alcohol consumption are at increased risk of colorectal cancer (CRC), reports a study, which shows that alcohol intake may trigger colorectal carcinogenesis through mechanisms operating across major molecular pathways for CRC.

Heavy alcohol consumption raises CRC risk

10 Jun 2026

$TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients$

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

Patients with radiographic axial spondyloarthritis (r-axSpA) who have been exposed to tumour necrosis factor inhibitor (TNFi) and interleukin (IL)-17 inhibitor (IL-17i) appear to have a lower risk of osteoporosis, but not hip fracture, than biologic disease-modifying antirheumatic drug (bDMARD)-naïve individuals, a recent study has shown.

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

10 Jun 2026

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026 bởi

Individuals with chronic hepatitis D (CHD) may benefit from lonafarnib boosted with ritonavir (LNF/RTV) alone or in combination with peg-interferon-alfa (PEG), findings from the phase III D-LIVR trial have shown.

LNF-based regimens may alter trajectory of CHD treatment

10 Jun 2026

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

10 Jun 2026

Tỷ lệ mắc các bệnh dị ứng cơ địa ở trẻ nhỏ sinh tại Hồng Kông đã tăng 46% trong đại dịch COVID-19, có thể liên quan đến sự thay đổi của hệ vi sinh đường ruột ở trẻ sơ sinh do việc khử trùng mạnh mẽ. SIM03 và SIM05, các công thức sữa chứa lợi khuẩn được phát triển với sự hỗ trợ của trí tuệ nhân tạo (AI), đã chứng minh làm giảm mức độ nặng của chàm và cải thiện chất lượng sống (QoL) ở trẻ em và người lớn, bằng cách điều hòa hệ vi sinh đường ruột.

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

10 Jun 2026

$Lutikizumab shows promise in refractory hidradenitis suppurativa$

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Treatment with lutikizumab appears to improve outcomes in patients with moderate-to-severe hidradenitis suppurativa (HS) who have not responded to anti-TNF therapy, according to a phase II trial.

Lutikizumab shows promise in refractory hidradenitis suppurativa

10 Jun 2026

Tin tức & Cập nhật

Xem bài viết Đa khoa

Xem

Chuyên ngành:

PROTEUS sets new course for prostate cancer

PROTEUS sets new course for prostate cancer

Azithromycin of little benefit in preschool-age children with acute wheezing

Azithromycin of little benefit in preschool-age children with acute wheezing

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

Real-world data confirm effectiveness of dupilumab in eosinophilic esophagitis

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

One in five patients with chronic HBV infection achieves functional cure with bepirovirsen

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Rheumatology patients must undergo screening for anxiety, depression, FM: study

Heavy alcohol consumption raises CRC risk

Heavy alcohol consumption raises CRC risk

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients

LNF-based regimens may alter trajectory of CHD treatment

LNF-based regimens may alter trajectory of CHD treatment

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

Trẻ sinh ra trong đại dịch có nguy cơ mắc các bệnh lý liên quan đến bệnh dị ứng do cơ địa cao hơn 46%

Lutikizumab shows promise in refractory hidradenitis suppurativa

Lutikizumab shows promise in refractory hidradenitis suppurativa